A Study Evaluating the Effect of Botulinum Toxin Type A on Semen Quality in Patients With Benign Prostatic Hyperplasia

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

August 31, 2009

Primary Completion Date

June 30, 2012

Study Completion Date

August 31, 2012

Conditions
Benign Prostatic Hyperplasia
Interventions
BIOLOGICAL

Botulinum Toxin Type A

OnabotulinumtoxinA (botulinum toxin Type A) 200U injected into the prostate on Day 1.

DRUG

Placebo (saline)

Saline injected into the prostate on Day 1.

Trial Locations (1)

Unknown

Los Angeles

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Allergan

INDUSTRY